Ana Marisa Chudzinski-Tavassi Selected Research

ciliobrevin A

1/2016

Specific role of cytoplasmic dynein in the mechanism of action of an antitumor molecule, Amblyomin-X.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ana Marisa Chudzinski-Tavassi Research Topics

Disease

16	Neoplasms (Cancer) 05/2022 - 12/2010
3	COVID-19 10/2022 - 01/2022
3	Melanoma (Melanoma, Malignant) 05/2022 - 04/2016
3	Inflammation (Inflammations) 01/2020 - 07/2005
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2016 - 02/2012
2	Osteoarthritis 12/2022 - 01/2020
2	Mitochondrial Diseases (Mitochondrial Disease) 04/2016 - 06/2013
2	Disseminated Intravascular Coagulation 05/2007 - 07/2005
1	Neurodegenerative Diseases (Neurodegenerative Disease) 12/2022
1	Diabetic Neuropathies (Diabetic Neuropathy) 12/2022
1	Pain (Aches) 12/2022
1	Neuroinflammatory Diseases 12/2022
1	Infections 10/2022
1	Neoplasm Metastasis (Metastasis) 12/2020
1	Brain Neoplasms (Brain Tumor) 04/2020
1	Glioblastoma (Glioblastoma Multiforme) 04/2020
1	Rheumatoid Arthritis 01/2020
1	Neuroepithelial Neoplasms (Gliomatosis Cerebri) 10/2019
1	Thromboinflammation 01/2019
1	Ependymoma 04/2018
1	Wounds and Injuries (Trauma) 01/2016
1	Acanthamoeba Keratitis 01/2015
1	Cysts 09/2013
1	Corneal Ulcer 09/2013
1	Thrombophilia 04/2013
1	Urologic Neoplasms (Urological Cancer) 02/2012
1	Pathologic Processes 01/2012
1	Acute Kidney Injury (Acute Renal Failure) 05/2008
1	Hemorrhage 05/2007
1	Hypotension (Low Blood Pressure) 10/2004
1	Edema (Dropsy) 05/2004
1	Snake Bites (Snake Bite) 06/2002

Drug/Important Bio-Agent (IBA)

10	Proteins (Proteins, Gene)FDA Link 10/2022 - 10/2004
6	VenomsIBA 01/2020 - 06/2002
4	Proteasome Endopeptidase Complex (Proteasome)IBA 01/2016 - 12/2010
3	Hemostatics (Antihemorrhagics)IBA 01/2022 - 09/2011
3	Recombinant ProteinsIBA 02/2019 - 04/2013
2	CollagenIBA 12/2022 - 01/2016
2	Pharmaceutical PreparationsIBA 05/2022 - 01/2020
2	Metalloproteases (Metalloproteinases)IBA 01/2019 - 06/2002
2	Snake Venoms (Snake Venom)IBA 01/2019 - 10/2004
2	monocrystalline iron oxide nanoparticle (MION)IBA 11/2018 - 04/2018
2	CaspasesIBA 04/2016 - 06/2013
2	Fibrinogen (Factor I)FDA Link 05/2008 - 07/2005
1	TubulinIBA 12/2022
1	NeuropeptidesIBA 12/2022
1	Substance PIBA 12/2022
1	Advanced Glycation End ProductsIBA 12/2022
1	Immunoglobulins (Immunoglobulin)IBA 10/2022
1	AntibodiesIBA 06/2022
1	Trypsin InhibitorsIBA 05/2022
1	Protease Inhibitors (Protease Inhibitor)IBA 05/2022
1	Kallikreins (Kallikrein)IBA 01/2022
1	ReninIBA 01/2022
1	AngiotensinsIBA 01/2022
1	KininsIBA 01/2022
1	Long Noncoding RNAIBA 04/2020
1	MicroRNAs (MicroRNA)IBA 04/2020
1	RNA (Ribonucleic Acid)IBA 01/2020
1	Temozolomide (Temodar)FDA LinkGeneric 10/2019
1	Cisplatin (Platino)FDA LinkGeneric 10/2019
1	C-Type Lectins (C-Type Lectin)IBA 01/2019
1	Viper Venoms (Viper Venom)IBA 01/2019
1	rhodamine BIBA 11/2018
1	CalciumIBA 04/2016
1	Cytochromes c (Cytochrome c)IBA 04/2016
1	Endoplasmic Reticulum Chaperone BiPIBA 04/2016
1	Bortezomib (Velcade)FDA Link 04/2016
1	Dyneins (Dynein)IBA 01/2016
1	LipidsIBA 01/2016
1	TrypsinIBA 01/2016
1	ciliobrevin AIBA 01/2016
1	Cyclin D1IBA 01/2016
1	Peptide Hydrolases (Proteases)FDA Link 01/2015
1	Virulence Factors (Pathogenicity Factors)IBA 01/2015
1	chlorhexidine gluconate (Dyna-Hex)FDA LinkGeneric 09/2013
1	Coloring Agents (Dyes)IBA 09/2013
1	Trypan Blue FDA Link 09/2013
1	BiguanidesIBA 09/2013
1	polihexanideIBA 09/2013
1	Proteasome InhibitorsIBA 06/2013
1	Reactive Oxygen Species (Oxygen Radicals)IBA 06/2013
1	AnticoagulantsIBA 04/2013
1	Heparin (Liquaemin)FDA LinkGeneric 04/2013
1	LipocalinsIBA 01/2012
1	Serine Proteases (Serine Protease)IBA 12/2010
1	UbiquitinIBA 12/2010
1	fibrin fragment D (D-dimer)IBA 07/2005
1	Lonomia obliqua prothrombin activator proteaseIBA 07/2005
1	Thrombin FDA Link 07/2005
1	Prothrombin (Factor II)IBA 07/2005
1	CoagulantsIBA 05/2004
1	Peptides (Polypeptides)IBA 06/2002
1	Serine (L-Serine)FDA Link 06/2002
1	AngiostatinsIBA 06/2002

Therapy/Procedure

3	Therapeutics 10/2022 - 06/2013
1	Injections 01/2020
1	Intraventricular Infusions 04/2018
1	Radiotherapy 02/2012
1	Drug Therapy (Chemotherapy) 02/2012